Basic Information
The International iReceptor Plus Consortium Aims to Facilitate the Storage, Integration, and Controlled Sharing of Human Immune Data for a Wide Range of Clinical and Scientific Purposes. This Four-Year Project, Jointly Funded by the European Union and the Canadian Government, Aims to Develop an Innovative Platform to Integrate Distributed Adaptive Immune Receptor Repertoire Sequence (AIRR-seq) Databases. The Information Will Be Used to Improve Personalized Medicine and Immunotherapy for Cancer, Inflammatory and Autoimmune Diseases, Allergies, and Infectious Diseases.
iReceptor Plus
Israel
unclear
--
info@ireceptor-plus.com

